Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4470549 | 0.81 | HKDC1 (0.39) | — | |
| SCHEMBL4739994 | 0.62 | PIK3CA (0.37) | POLBMAPTSMN1; SMN2 | |
| SCHEMBL23271765 | 0.60 | KDM4E (0.43) | KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL30003486 | 0.60 | KDM4E (0.43) | KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL3485829 | 0.56 | PLK1 (0.31) | — | |
| SCHEMBL3513421 | 0.56 | TYR (0.40) | — | |
| SCHEMBL7115300 | 0.54 | ADORA3 (0.37) | KDM4EPOLBMAPT | |
| SCHEMBL15414521 | 0.53 | TYR (0.40) | — | |
| SCHEMBL11919734 | 0.53 | ELANE (0.56) | KDM4EPOLBMAPT | |
| SCHEMBL11919735 | 0.53 | ELANE (0.56) | KDM4EPOLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7582675-B2 | Flavonoid compound and process for producing the same | POKKA CORPORATION (JP) | 2009-09-01 | — | — | US | disclosed |
| US-20060270009-A1 | Flavonoid compound and process for producing the same | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2006-11-30 | — | — | US | disclosed |
| US-7138429-B2 | Flavonoid compound and process for producing the same | JAPAN SCI. TECH. CORP. (JP) | 2006-11-21 | — | — | US | disclosed |
| EP-1369489-B1 | FLAVONOID COMPOUND AND PROCESS FOR PRODUCING THE SAME | JAPAN SCIENCE & TECH CORP (JP) | 2006-08-23 | — | — | EP | disclosed |
| US-20040152762-A1 | Flavonoid compound and process for producing the same | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2004-08-05 | — | — | US | disclosed |
| EP-1369489-A1 | FLAVONOID COMPOUND AND PROCESS FOR PRODUCING THE SAME | Japan Science and Technology Corporation (JP) | 2003-12-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152762-A1 | Flavonoid compound and process for producing the same | ERG28, TFPI, HES1 | KDM4E 1126/4885POLB 2116/4885MAPT 3583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.